Medications
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.
May 10, 2022
0
0
Page 19 - News tagged with drug company
Health
Social justice claim is Big Tobacco's smoke screen in menthol regulation battle
The U.S. Food and Drug Administration (FDA) released a proposal last week to ban menthol cigarettes, which account for over a third of cigarette consumption. They say the move to eliminate menthol—a minty flavor that reduces ...
May 4, 2022
0
2
Other
Change at the top for Biogen after Alzheimer's drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.
May 3, 2022
0
10
Pediatrics
Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.
Apr 28, 2022
0
7
Vaccination
Moderna seeks to be 1st with COVID shots for littlest kids
Moderna is seeking to be the first to offer COVID-19 vaccine for the youngest American children, as it asked the Food and Drug Administration Thursday to clear low-dose shots for babies, toddlers and preschoolers.
Apr 28, 2022
0
0
Biomedical technology
Researchers create 3D model for rare neuromuscular disorders, setting stage for clinical trial
A scientific team supported by the National Institutes of Health has created a tiny, bioengineered 3D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair ...
Apr 19, 2022
0
5
Medications
RACE Act increased the number of cancer drugs with required studies for use in pediatric patients
In its first year of implementation, the RACE Act has resulted in increased requirements for more recently approved cancer drugs to be studied for potential use in pediatric patients, according to data presented at the AACR ...
Apr 11, 2022
0
3
Genetics
An immune cell 'fingerprint' reveals path for better treatment of autoimmune diseases
Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.
Apr 7, 2022
0
507
Other
'Patient influencers' are booming on social media. Is that good or bad?
"OMG. Have you guys heard about this?"
Apr 5, 2022
0
2
Medical economics
Should COVID-19 vaccines and drugs be not-for-profit?
From HIV to Ebola, and now COVID-19, inequality in access to medicines and vaccines has been prevalent in developing countries for decades.
Mar 30, 2022
0
2
